Smruthi Organics Receives ANVISA GMP Certificate for Unit II
Smruthi Organics Ltd 路 Others (Uncategorized) 路 12 Nov 2026, 4:44 pm
Smruthi Organics Receives ANVISA GMP Certificate for Unit II Smruthi Organics has received the Brazilian Good Manufacturing Practices (GMP/CBPF) Certificate from the Brazilian Health Regulatory Agency (ANVISA) for its Unit II facility in Chincholi, Solapur, Maharashtra. Issued pursuant to Resolution RE No. 4,179 published on 26th Oct'26, the certification approves compliance for the active pharmaceutical ingredient (API) Levanlodipine Besylate Hemipentahydrate. The certificate is valid until 26th Oct'28, strengthening the company's regulatory compliance and strategic market presence in the Brazilian pharmaceutical sector.
Original exchange filing (PDF)
More announcements from Smruthi Organics Ltd
- Outcome of Board Meeting : Unaudited Financial Results for the second quarter and half year ended 30th September 2026 路 13 Nov 2026
- Financial Results for quarter and half year ended 30.09.2026 路 13 Nov 2026
- Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Prior Intimation of Board .... 路 13 Nov 2026
- Intimation regarding receipt of ANVISA Inspection Report 路 21 Oct 2026
- Approval from CG for appointment of Ms SmruthI eaga as Whoel Time Director 路 07 Oct 2026
- Scrutinisers Report and Voting Results of AGM 路 11 Aug 2026
- Outcome of 37th Annual General Meeting held today i.e 10th August 2026 路 10 Aug 2026
- Un Audited Quarterly Results of the Company for the first quarter ended 30th June 2026 路 10 Aug 2026
